What is RXO's interest income (expense), nonoperating?

RXO (RXO) reported interest income (expense), nonoperating of -$9M in Q1 2026.

How has RXO's interest income (expense), nonoperating changed year-over-year?

RXO's interest income (expense), nonoperating decreased by 0.0% year-over-year, from -$9M to -$9M.

What is the long-term trend for RXO's interest income (expense), nonoperating?

Over 3 years (2022 to 2025), RXO's interest income (expense), nonoperating has grown at a 106.1% compound annual growth rate (CAGR), from -$4M to -$35M.

RXO RXO Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Ryan Specialty HoldingsRYAN

——

Segments

By segment

See full

Reportable Segment-$9M0.0%

Other financials

Income statement

See full

Revenue$1.4B-0.6%

Gross profit$254.0M-9.3%

Operating income-$28.0M+6.7%

Net income-$36.0M-16.1%

EPS (diluted)-$0.21-16.7%

Balance sheet

See full

Cash & equivalents$22.0M+37.5%

Total debt$716.0M+2.0%

Total equity$1.5B-4.9%

Total assets$3.3B-1.1%

Cash flow

See full

Operating cash flow-$7.0M-250%

CapEx$17.0M+13.3%

Free cash flow-$24.0M-41.2%

Valuation

See full

Market cap$4.2B-23.0%

Profitability

See full

Gross margin19.3%-1.5pp

Operating margin-1.3%-0.1pp

Net margin-1.8%-0.8pp

FCF margin-1.4%—

Returns & leverage

See full

Return on equity-6.8%-2.9pp

Debt / equity0.5×0.0×

Current ratio1.3×0.0×

Where this comes from

Reported directly by RXO in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: RXO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about RXO's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RXO's interest income (expense), nonoperating?: RXO (RXO) reported interest income (expense), nonoperating of -$9M in Q1 2026.
How has RXO's interest income (expense), nonoperating changed year-over-year?: RXO's interest income (expense), nonoperating decreased by 0.0% year-over-year, from -$9M to -$9M.
What is the long-term trend for RXO's interest income (expense), nonoperating?: Over 3 years (2022 to 2025), RXO's interest income (expense), nonoperating has grown at a 106.1% compound annual growth rate (CAGR), from -$4M to -$35M.